GRF6021
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for GRF6021, covering 2022-05-09 to 2024-03-13. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Effect of GRF6021 on Postoperative Recovery Following Primary Hip or Knee Arthroplasty [Phase 2]